Advertisement Synthetech Announces Fiscal 2009 Results - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Synthetech Announces Fiscal 2009 Results

45% increase of revenue to $6.6 million

Synthetech has announced financial results for its fiscal fourth quarter and fiscal year, which ended March 31, 2009. For the fourth quarter ended March 31, 2009, revenue was $6.6 million, a 45% increase from revenue of $4.6 million for the same period last year.

Gross income for the current quarter was $2.0 million, compared to gross income of $1.1 million for the same period last year. Operating income for the current quarter was $704000 compared to $128000 for the same period last year. Net income for the fourth quarter ended March 31, 2009 was $657000, or $0.04 per share, compared to $113000 or $0.01 per share, in last year’s corresponding period.

The Company reported revenue of $19.9 million for fiscal 2009, a 36% increase from revenue of $14.6 million in fiscal 2008. Gross income in fiscal 2009 was $5.5 million, compared to gross income in fiscal 2008 of $2.9 million. Net income for fiscal 2009 was $1.2 million, or $0.08 per share, compared to a net loss for fiscal 2008 of $1.2 million, or $0.08 per share.